| MolName | 4-[6-[(5Z)-4-oxo-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-3-yl]hexanoylamino]benzoic acid |
| MolecularFormula | C21H20N2O4S3 |
| Smiles | OC(c(cc1)ccc1NC(CCCCCN(C(/C(/S1)=C/c2cccs2)=O)C1=S)=O)=O |
| InChI | InChI=1S/C21H20N2O4S3/c24-18(22-15-9-7-14(8-10-15)20(26)27)6-2-1-3-11-23-19(25)17(30-21(23)28)13-16-5-4-12-29-16/h4-5,7-10,12-13H,1-3,6,11H2,(H,22,24)(H,26,27) |
| InChIK | UCQNUKRINIYHNW-UHFFFAOYSA-N |
| TotalMolweight | 460.598 |
| Molweight | 460.598 |
| MonoisotopicMass | 460.058518 |
| CLogP | 3.3588 |
| CLogS | -5.515 |
| H Acceptors | 6 |
| H Donors | 2 |
| TotalSurfaceArea | 340.53 |
| Relative PSA | 0.3908 |
| PolarSurfaceArea | 172.34 |
| Druglikeness | -2.9389 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.66667 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 9 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 8 |
| Symmetricatoms | 2 |
| Amides | 2 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 4-[6-[(5Z)-4-oxo-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-3-yl]hexanoylamino]benzoic acid | 2 - 4-[6-[(5Z)-4-oxo-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-3-yl]hexanoylamino]benzoic acid